Anemia Drugs Market Forecast Showing Industry Progress And Growth Trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Anemia Drugs Market During The Forecast Period?

The anemia drugs market has experienced substantial expansion recently. It is forecast to grow from $15.77 billion in 2025 to $16.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.5%. The market’s growth in past periods is attributable to iron deficiency prevalence, chronic kidney disease growth, hospital transfusion usage, maternal anemia incidence, and dietary deficiency.

The anemia drugs market size is anticipated to undergo significant expansion in the coming years. It is projected to increase to $22.69 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.6%. This expected growth during the forecast period is attributable to an aging population’s increase, effective management of chronic disease anemia, the adoption of injectable iron, the expansion of home healthcare, and preventive supplementation. Prominent trends observed in the forecast period include the rising utilization of erythropoiesis-stimulating agents, the progression of intravenous iron therapy, the broadening of home-based anemia management, a greater emphasis on chronic disease anemia, and a shift towards combination supplement therapy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24141&type=smp

Which Primary Drivers Are Impacting The Anemia Drugs Market Growth?

A growing emphasis on personalized medicine is anticipated to drive the expansion of the anemia drugs market in the future. This medical strategy involves customizing treatment and healthcare choices according to an individual’s unique genetic profile, lifestyle factors, and environmental influences. The heightened interest in personalized medicine stems from progress in genomic sequencing, enabling more accurate detection of genetic variations specific to individuals that are associated with disease and how they respond to treatment. It aids in the development of anemia drugs by facilitating customized therapies derived from individual genetic profiles, thereby enhancing drug effectiveness and reducing unwanted side effects, which leads to improved patient results. For example, data from February 2024, provided by the US-based non-profit Personalized Medicine Coalition, indicates that the U.S. Food and Drug Administration (FDA) in 2023 gave approval to 16 novel personalized treatments for individuals with rare conditions, marking a substantial rise from 6 such approvals in 2022. Consequently, the heightened attention on personalized medicine is a key factor boosting the expansion of the anemia drugs market.

What Are The Main Segments Within The Anemia Drugs Market Segment Structure?

The anemia drugs market covered in this report is segmented –

1) By Drug Type: Dietary Supplements, Medicines

2) By Therapy Type: Oral Iron Therapy, Red Blood Cell Transfusion, Parental Iron Therapy, Other Therapy Types

3) By Anemia Type: Iron Deficiency Anemia, Sickle Cell Anemia, Aplastic Anemia, Hemolytic Anemia, Pernicious Anemia, Other Anemia Types

4) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy

5) By End-User: Clinic, Healthcare, Home Healthcare

Subsegments:

1) By Dietary Supplements: Iron Supplements, Vitamin B12 Supplements, Folic Acid Supplements, Multivitamin And Mineral Supplements

2) By Medicines: Erythropoiesis-Stimulating Agents (ESAs), Iron Chelating Agents, Corticosteroids, Immunosuppressants, Luspatercept And Related Agents

Which Trends Are Guiding The Direction Of The Anemia Drugs Market?

Major companies in the anemia drugs market are prioritizing innovative drug developments, such as oral HIF-PHI (hypoxia-inducible factor prolyl hydroxylase inhibitors), to enhance iron metabolism and increase red blood cell production for more effective anemia treatments. Oral HIF-PHI (Hypoxia-Inducible Factor Prolyl Hydroroxylase Inhibitors) are a category of oral medications that specifically target and inhibit prolyl hydroxylase enzymes, which are involved in regulating the hypoxia-inducible factor (HIF) pathway. For example, in February 2023, GSK plc, a pharmaceutical company based in the UK, released Jesduvroq, a treatment formulated to boost red blood cell production and manage anemia in adult patients with chronic kidney disease. This innovative anemia drug system offers enhanced iron metabolism, improved red blood cell production, and personalized therapies. Jesduvroq proves highly effective, stimulating red blood cell production and alleviating anemia in chronic kidney disease patients by optimizing iron metabolism for superior treatment outcomes.

Who Are The Companies Participating In The Anemia Drugs Market?

Major companies operating in the anemia drugs market are Pfizer Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Fresenius SE & Co. KGaA, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Biocon Limited, Akebia Therapeutics Inc., Apellis Pharmaceuticals Inc., Rockwell Medical Inc., Pharmacosmos A/S, Shield Therapeutics plc, Covis Pharma GmbH, AdvaCare Pharma LLC, BioLineRx Ltd., Bluebird Bio Inc.

Get The Full Anemia Drugs Market Report:

https://www.thebusinessresearchcompany.com/report/anemia-drugs-global-market-report

Which Region Has The Greatest Market Share In The Anemia Drugs Market?

North America was the largest region in the anemia drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anemia drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anemia Drugs Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anemia-drugs-global-market-report

Browse Through More Reports Similar to the Global Anemia Drugs Market 2026, By The Business Research Company

Anemia And Other Blood Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Chemotherapy Induced Anemia Market Report 2026

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-anemia-global-market-report

Hematology Drug Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795